Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)
Status:
Not yet recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
The metabolic syndrome population is at high-risk of cardiovascular diseases and diabetes.
How to effectively control the risk factors of this population is the key to primary
prevention of cardiovascular diseases and diabetes in China. This study aims to explore the
efficacy and safety of an intervention strategy with berberine that can effectively treat a
variety of risk factors (hyperglycemia, dyslipidemia, hypertension).